SCHEMBL17385341

SCHEMBL17385341

O=Cc1cc2sc(N3CCCCC3)nc2s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.51
RAB9A P51151 13/20 0.46
SMN1; SMN2 Q16637 12/20 0.46
NPC1 O15118 11/20 0.46
HPGD P15428 4/20 0.46
HSD17B10 Q99714 3/20 0.46
ALOX15 P16050 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPT P10636 4/20 0.44
TP53 P04637 3/20 0.44
LMNA P02545 1/20 0.44
USP2 O75604 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.43
TSHR P16473 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
APOBEC3A P31941 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22677809 0.82 SMN1; SMN2 (0.49) ALDH1A1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL22677937 0.82 CRBN (0.36) ALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL22677989 0.82 HRH4 (0.39) ALDH1A1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL22678226 0.80 IKBKB (0.37) ALDH1A1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL17385328 0.78 RAB9A (0.48) ALDH1A1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL22678180 0.77 CYP2A6 (0.33) ALDH1A1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL22678205 0.77 RAB9A (0.45) RAB9ANPC1MAPTTP53LMNA
SCHEMBL17372954 0.76 RAB9A (0.43) ALDH1A1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL5039729 0.76 RAB9A (0.46) ALDH1A1RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL22677789 0.76 TP53 (0.41) ALDH1A1RAB9ASMN1; SMN2NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153756-A1 ANTI-INFECTIVE COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2022-05-19 US disclosed
EP-3157904-B1 ANTI-INFECTIVE COMPOUNDS PASTEUR INSTITUT KOREA (KR) 2020-11-18 EP disclosed
US-20170121349-A1 Anti-Infective Compounds INSTITUT PASTEUR KOREA (KR) 2017-05-04 US disclosed
WO-2015193506-A1 ANTI-INFECTIVE COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2015-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153756-A1 ANTI-INFECTIVE COMPOUNDS RABGGTB, ELANE, SERPINB1 ALDH1A1 3932/4885RAB9A 1091/4885SMN1; SMN2 4839/4885
US-20170121349-A1 Anti-Infective Compounds FNTB, LSS, PGLS ALDH1A1 1595/4885RAB9A 594/4885SMN1; SMN2 4810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.